China has strongly opposed former President Donald Trump’s recent move to tie trade tariffs to the ongoing fentanyl crisis, calling the connection unjustified and misleading. In a statement released by the Chinese Ministry of Foreign Affairs, officials expressed their dissatisfaction with the rhetoric, asserting that China has been actively working to combat the illicit production and trafficking of fentanyl and its analogs.
Trump’s remarks, made during his tenure in office, suggested that China should be held responsible for the flow of fentanyl into the United States, which has contributed to the opioid epidemic. In response, Chinese officials highlighted the nation’s ongoing efforts to curb the production of the synthetic opioid, noting that China had already imposed strict regulations on the substance years ago.
“Fentanyl trafficking is a global problem, and it is unfair to single out China,” said a spokesperson for the Chinese government. “We are committed to working with international partners to address this issue, but linking it to trade tariffs is a misguided approach.”
The US has seen a significant rise in fentanyl-related deaths, primarily from illicit drugs trafficked from various countries, including China. While China has made strides in controlling the export of fentanyl and related substances, the issue remains a contentious point in US-China relations, with both sides at odds over the scale of the crisis and the most effective ways to combat it.
The dispute comes at a time when trade tensions between the two countries remain high, with tariffs still affecting key sectors of the global economy. As both nations seek to navigate this complex issue, China’s rejection of Trump’s tariff linkage raises questions about future diplomatic efforts to resolve the fentanyl crisis and broader trade conflicts.
source: asahi.com